STOCK TITAN

Inspiring Young Minds: HRH the Princess Royal Helps Illumina Celebrate DNA Day

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Very Positive)
Tags

In celebration of DNA Day, Illumina in Cambridge, United Kingdom, hosted 150 students for hands-on science activities, inspiring young scientists to pursue careers in STEM. HRH The Princess Royal visited the event, emphasizing the importance of genomics and STEM education. The Future Is Bright initiative, promoting global genomic literacy, engages 100,000 learners annually, aiming to reach 5 million by 2030.

In occasione del Giorno del DNA, Illumina a Cambridge, Regno Unito, ha ospitato 150 studenti per delle attività scientifiche pratiche, ispirando i giovani scienziati a intraprendere carriere nel campo STEM. S.A.R. La Principessa Reale ha partecipato all'evento, sottolineando l'importanza della genomica e dell'educazione STEM. L'iniziativa 'Il Futuro è Luminoso', che promuove l'alfabetizzazione genomica globale, coinvolge annualmente 100.000 apprendenti, con l'obiettivo di raggiungere 5 milioni entro il 2030.
En la celebración del Día del ADN, Illumina en Cambridge, Reino Unido, recibió a 150 estudiantes para actividades científicas prácticas, inspirando a jóvenes científicos a seguir carreras en STEM. La Princesa Real HRH visitó el evento, enfatizando la importancia de la genómica y la educación en STEM. La iniciativa 'El Futuro es Brillante', que promueve la alfabetización genómica global, involucra anualmente a 100,000 aprendices, con el objetivo de alcanzar los 5 millones para 2030.
DNA의 날을 기념하여 영국 케임브리지에 위치한 일루미나는 150명의 학생들을 초대하여 실용 과학 활동을 진행하였고, 이는 젊은 과학자들이 STEM 분야의 경력을 추구하도록 영감을 주었습니다. 왕립 HRH 공주가 이 행사에 참석하여 게놈학과 STEM 교육의 중요성을 강조하였습니다. '밝은 미래' 이니셔티브는 전 세계적인 게놈 문해력을 증진하고 있으며, 매년 100,000명의 학습자를 참여시키며, 2030년까지 500만 명에게 도달할 목표를 가지고 있습니다.
À l'occasion de la Journée de l'ADN, Illumina à Cambridge, Royaume-Uni, a accueilli 150 étudiants pour des activités scientifiques pratiques, inspirant les jeunes scientifiques à poursuivre des carrières dans les domaines STEM. SAR La Princesse Royale a visité l'événement, soulignant l'importance de la génomique et de l'éducation STEM. L'initiative 'L'Avenir est Lumineux', qui promeut l'alphabétisation génomique mondiale, engage annuellement 100 000 apprenants, avec l'objectif d'atteindre 5 millions d'ici 2030.
Zur Feier des DNA-Tages hat Illumina in Cambridge, Vereinigtes Königreich, 150 Schüler zu praktischen Wissenschaftsaktivitäten eingeladen, um junge Wissenschaftler zu ermutigen, Karrieren in den MINT-Fächern zu verfolgen. Die Königliche Hoheit Prinzessin Royal besuchte die Veranstaltung und betonte die Bedeutung der Genomik und MINT-Bildung. Die Initiative 'Die Zukunft ist hell', die weltweite genomische Bildung fördert, bindet jährlich 100.000 Lernende ein und zielt darauf ab, bis 2030 5 Millionen zu erreichen.
Positive
  • Celebration of DNA Day with hands-on science activities to inspire young scientists

  • HRH The Princess Royal's visit highlights the importance of genomics and STEM education

  • The Future Is Bright initiative engages 100,000 learners annually, aiming for 5 million by 2030

Negative
  • None.

In Cambridge, United Kingdom, Illumina champions STEM education opportunities with local students

NORTHAMPTON, MA / ACCESSWIRE / April 29, 2024 / Illumina
Originally published on Illumina News Center

On April 25, Illumina opened its doors in Granta Park, Cambridge, to celebrate DNA Day. This annual event marks a significant milestone in the history of science: the successful completion of the Human Genome Project in 2003 and the groundbreaking discovery of DNA's double helix structure by James Watson and Francis Crick, along with Rosalind Franklin, in 1953.

This year's DNA Day festivities at Illumina were joined by 150 enthusiastic children from schools in underserved areas of Cambridgeshire. The learners engaged in hands-on science activities, including extracting DNA from strawberries, and toured one of Illumina's state-of-the-art laboratories. This behind-the-scenes glimpse into the world of genomic research was designed to inspire young scientists who may one day play pioneering roles in research and innovation at companies like Illumina.

During the event, the Illumina team was honored to welcome Anne, The Princess Royal, to Illumina's Europe regional headquarters in Cambridge. The visit gave the students a unique opportunity to interact with King Charles's sister as well as learn about the importance of genomics firsthand. The Princess Royal champions STEM education, encouraging kids to explore the world of science and increasing the presence of women in the field.

In keeping with the spirit of DNA Day, Illumina hosted their annual global genomic literacy initiative, The Future Is Bright, which exemplifies the company's commitment to promoting equitable access to STEM education and inspiring the next generation of scientists. Throughout April, Illumina partners with schools and nonprofit organizations, such as Form the Future and Cambridge Science Centre, to provide educational programs and activities for learners of all ages.

Anne Bailey, CEO of Form the Future, says, "We are immensely grateful for Illumina's support as our corporate partner, enabling us to engage primary school students in stimulating STEM activities. Their funding and dedication to releasing staff to work alongside us are instrumental in inspiring young minds and fostering a belief that a future in STEM is within reach, particularly for those from disadvantaged backgrounds. Together, we're bridging the gap in our local economy, empowering a diverse array of students to pursue rewarding careers in the life sciences and beyond."

In 2024, an expected 100,000 learners globally will participate in The Future Is Bright; in the UK alone, some 10,000 pupils benefited from the campaign and its spirit of collaboration and service. Watch the video below to see the highlights of the day.

Last year, The Future Is Bright hosted 130 events, reaching students in six countries and every US state. The program was powered by 1500 employee volunteer hours and 2300 donated strawberry DNA extraction kits. More than 1600 community partners and schools participated, and 71% of the American classrooms were part of Title 1 schools where low-income families make up at least 40% of enrollment. As of December 2023, Illumina has reached a total of 1.6 million STEM learners, as part of its target to reach 5 million by 2030. The Future Is Bright campaign is a key program in achieving this goal.

Through hands-on activities, engaging interactions, and valuable partnerships, Illumina continues its commitment to empowering young scientists and paving the way for a brighter future fueled by science and innovation.

View additional multimedia and more ESG storytelling from Illumina on 3blmedia.com.

Contact Info:
Spokesperson: Illumina
Website: https://www.3blmedia.com/profiles/illumina
Email: info@3blmedia.com

SOURCE: Illumina



View the original press release on accesswire.com

FAQ

What is the purpose of Illumina celebrating DNA Day?

To inspire young scientists and promote STEM education

Who visited the DNA Day event at Illumina in Cambridge?

HRH The Princess Royal

What is The Future Is Bright initiative about?

It promotes global genomic literacy and engages 100,000 learners annually

How many students are expected to participate in The Future Is Bright in 2024?

100,000 learners globally

What is Illumina's goal for The Future Is Bright initiative by 2030?

To reach 5 million learners

Illumina, Inc.

NASDAQ:ILMN

ILMN Rankings

ILMN Latest News

ILMN Stock Data

18.32B
158.41M
0.24%
94.5%
3.32%
Analytical Laboratory Instrument Manufacturing
Manufacturing
Link
United States of America
SAN DIEGO

About ILMN

at illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. these studies will help make the realization of personalized medicine possible. with such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. as a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. illumina’s innovative, array-based solutions for dna, rna, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.